| abstract |
The present invention relates to a spectrum-based agranin type 2 receptor agonist and its use, and more particularly, to a peptide agonist agent which improves the specificity and stability of the Galanin receptor type 2, Gyouhyyeonje is involved in the regulation of feeding, anxiety, emotion, and addiction, which is the physiological function of the body that is administered by Galanin Receptor Type 2, and has an effect of suppressing appetite, restoring anxiety disorder, and reducing pleasure addiction. Lt; RTI ID = 0.0 > type 2 < / RTI > receptor. |